Skip to Main Content

Paper Details

Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.
Br J Ophthalmol
26
2022
Author NameAffiliation
Philip J RosenfeldBascom Palmer Eye Institute, University of Miami Health System
  • 1 - 1

Datasets

Release 1.2